doi: 10.1016/j.jssas.2016.01.007 515 SevrinTAlexandre-GouabauMCCastellanoBAguesseAOuguerramKNgyuenPet al
Mechanistically, multi-omics analyses of cardiac and hepatic tissues revealed that semaglutide exerted these benefits by improving cardiac metabolism, interfering with pro-fibrotic and pro-hypertrophic signals, and by reducing systemic inflammation
Last week, researchers at Penn dropped a number worth your attention
Primary Research Areas Triple GIP/GLP-1/glucagon receptor agonism: Mechanistic studies dissecting receptor pharmacology, biased signaling and downstream pathways triggered by combined incretin and glucagon receptor activation
Some patients report fewer headaches when they inject on days with lighter schedulestiming flexibility reduces stress-related symptom amplification
The multivariate analysis reported that body weight at 12 months was 8.2 kg higher in the liraglutide group than placebo (8.23 kg, 95%CI: 1.6, 14.9 kg, p = 0.020, Supplementary Table 6.4)